Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug delivery
Pharma
FTC blasts Teva for 'improper' inhaler patents
After filing a challenge against more than 100 patents in the FDA’s Orange Book, the Federal Trade Commission has singled out Teva in an amicus brief.
Fraiser Kansteiner
Mar 25, 2024 10:04am
Appeals court backs Regeneron's antitrust suit against Novartis
Mar 19, 2024 10:40am
Formosa snags FDA nod for reformulation of decades-old steroid
Mar 5, 2024 11:36am
GSK's asthma inhaler market pull draws Warren's ire
Mar 5, 2024 10:57am
Theravance's COPD med Yupelri flunks head-to-head study
Jan 5, 2024 10:14am
Schott Pharma touts 2023 sales growth, Serbia expansion plans
Dec 20, 2023 3:25pm